My parents were one of the original families that brought JDRF to Canada. I was 13 years old in 1971 when my brother David was diagnosed with type 1 diabetes (T1D), and I was diagnosed at 15 years of age. My parents felt there wasn’t enough going on at the time regarding T1D research. It […]
Stigma and type 1 diabetes
An often under looked aspect of living with a chronic condition like type 1 diabetes (T1D) is the stigma that can accompany it. Generally, diabetes stigma can be defined as negative perceptions, judgment, discrimination, or a prejudice against someone because of their diabetes. The majority of T1D stigma derives from a lack of understanding of […]
Disordered eating and type 1 diabetes: Unmet need highlighted in a new UK report
People living with type 1 diabetes (T1D) are more likely to experience mental health challenges compared to those without diabetes. This includes disordered eating and eating disorders: those with T1D are 3-4 times more likely to experience these conditions. Eating disorders include anorexia, bulimia, binge eating disorders, and insulin omission or restriction to lose weight, […]
Introducing Fitness by Joanna
Hi, I’m Joanna! Born and raised in Ottawa, I now call Toronto my home. I’m passionate about health and fitness, PR/communications, all things food, travel and family! When were you diagnosed with type 1 diabetes, and can you share a little about what that was like? On March 16, 1998, I vividly remember looking down at […]
JDRF Canada announces new projects supported by the Mental Health and T1D Community Grants
People who live with diabetes are at an increased risk of mental health conditions such as anxiety, depression, eating disorders and diabetes distress (the feelings of stress, guilt and being overwhelmed that can result from diabetes management). There are diverse mental health needs across the type 1 diabetes (T1D) community in Canada, and a common […]
2023 Year in Review
If 2022 was a year of hope, 2023 was one of turning that hope into progress. And thanks to our incredible community of donors, volunteers, and supporters – we saw significant progress across all areas of type 1 diabetes (T1D) research and developed an even closer relationship with the amazing T1D community. From the generosity […]
A legacy of impact: Dave Prowten says goodbye to JDRF
Dear Friends, As I write this, my heart is overflowing with gratitude. Today, I am retiring from JDRF and it has been an incredible honour and privilege to be the President and CEO for over 10 years. I feel fortunate to have met so many fantastic people in the type 1 diabetes community – your passion, […]
Holiday gift guide for people living with type 1 diabetes
The holiday season is fast approaching, and you’re probably putting together your lists to choose the perfect gifts for the people in your life. Why not let JDRF help with your shopping. We’ve put together a gift guide with a few creative ideas for your loved ones living with type 1 diabetes (T1D) – but […]
Immune Therapy Preserves Beta Cell Function in Newly Diagnosed Type 1 Diabetes
Insulin, administered either by pump or multiple daily injection, remains the only available treatment for type 1 diabetes (T1D). JDRF is aiming to change that and move beyond insulin by accelerating the development of medicines that prevent, delay, or reverse T1D by targeting the autoimmune response, beta cells, or both. Supporting studies that explore how […]
JDRF Centre of Excellence at UBC marks two years of innovation in type 1 diabetes cure research
On November 2nd 2023, the JDRF Centre of Excellence at UBC held its second annual meeting to review research progress, celebrate advances, brainstorm challenges, map out next steps, and exchange knowledge about the lived experience of T1D – all with a view to accelerate the path towards a cure for T1D via the Centre’s research […]
New Trial Shows Benefits of Hybrid Closed Loop in Pregnancy
A JDRF UK-supported trial published in the New England Journal of Medicine and presented at the 2023 European Association for the Study of Diabetes conference demonstrated that hybrid closed loop technology helps pregnant individuals better manage their blood glucose compared to traditional insulin pumps or multiple daily injections. Authors say that hybrid closed-loop technology […]
New results from a clinical trial of once-weekly insulin
We are getting closer to the possibility of people with type 1 diabetes (T1D) needing to administer basal insulin only once a week instead of every single day, with Novo Nordisk announcing the latest results of its ONWARDS 6 clinical trial. What was the clinical trial studying? ONWARDS clinical trials, which have been ongoing for the […]